| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8466903 | Cytotherapy | 2018 | 8 Pages |
Abstract
Despite the standardized procedures applied to obtain commercial hPL, this study highlights the divergent effects of different preparations and emphasizes the importance of cellular ontology, donor age and cell proliferative capacity to optimize the osteogenic induction capabilities of mesenchymal stromal cells and design more effective cell-based therapeutic protocols.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Federica Boraldi, Jorge S. Burns, Angelica Bartolomeo, Massimo Dominici, Daniela Quaglino,